Rotational thromboelastometry (ROTEM)-based coagulation management in cardiac surgery and major trauma

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 26, Issue 6, 2012, Pages 1083-1093

  Tanaka, Kenichi A ^a   Bolliger, Daniel ^b   Vadlamudi, Ratna ^c   Nimmo, Alastair ^d  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

blood component transfusion; cardiac surgery; coagulation monitoring; rotational thromboelastometry; trauma

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; HEMOSTATIC AGENT; PROTHROMBIN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID;

BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TEST; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; CRYOPRECIPITATE; DAMAGE CONTROL RESUSCITATION; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HEART SURGERY; HEMATOLOGICAL PROCEDURE; HEMODILUTION; HEMOPHILIA; HEMOSTASIS; HUMAN; HYPOFIBRINOGENEMIA; INJURY; PARTIAL THROMBOPLASTIN TIME; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTHROMBIN TIME; RESUSCITATION; REVIEW; ROTATIONAL THROMBOELASTOMETRY; SIGNAL TRANSDUCTION; SURGICAL PATIENT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY; TREATMENT RESPONSE; TURNAROUND TIME;

BLOOD COAGULATION; CARDIAC SURGICAL PROCEDURES; DISEASE MANAGEMENT; HEMOSTASIS; HUMANS; POSTOPERATIVE HEMORRHAGE; THROMBELASTOGRAPHY; WOUNDS AND INJURIES;

EID: 84868301874     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2012.06.015     Document Type: Review

References (105)

1. G.J. Despotis, S.A. Santoro, E. Spitznagel Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation J Thorac Cardiovasc Surg 107 1994 271 279
2. L. Shore-Lesserson, H.E. Manspeizer, M. DePerio Thromboelastography- guided transfusion algorithm reduces transfusions in complex cardiac surgery Anesth Analg 88 1999 312 319
3. S.A. Mayer, F. Rincon Ultra-early hemostatic therapy for acute intracerebral hemorrhage Semin Hematol 43 2006 S70 S76
4. H. Schöchl, U. Nienaber, G. Hofer Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate Crit Care 14 2010 R55
5. E. Girdauskas, J. Kempfert, T. Kuntze Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: A prospective, randomized trial J Thorac Cardiovasc Surg 140 2010 1117 1124
6. K. Görlinger, D. Dirkmann, A.A. Hanke First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: A retrospective, single-center cohort study Anesthesiology 115 2011 1179 1191
7. T. Burnouf, M. Radosevich Nanofiltration of plasma-derived biopharmaceutical products Haemophilia 9 2003 24 37
8. A. Gröner Reply Pereira A. Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen: Risk comparison in the case of an emerging transfusion- transmitted infection Haematologica 92 2007 846 849 Haematologica 93 2008 e24 e26
9. M.C. Engoren, R.H. Habib, A. Zacharias Effect of blood transfusion on long-term survival after cardiac operation Ann Thorac Surg 74 2002 1180 1186
10. H. Khan, J. Belsher, M. Yilmaz Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients Chest 131 2007 1308 1314
11. C.G. Koch, L. Li, D.I. Sessler Duration of red-cell storage and complications after cardiac surgery N Engl J Med 358 2008 1229 1239
12. G.A. Watson, J.L. Sperry, M.R. Rosengart Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome J Trauma 67 2009 221 227
13. P. Toulon, Y. Ozier, A. Ankri Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery A multicenter study Thromb Haemost 101 2009 394 401
14. M.T. Ganter, C.K. Hofer Coagulation monitoring: Current techniques and clinical use of viscoelastic point-of-care coagulation devices Anesth Analg 106 2008 1366 1375
15. J.B. Segal, W.H. Dzik Transfusion Medicine/Hemostasis Clinical Trials Network Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: An evidence-based review Transfusion 45 2005 1413 1425
16. S. Yuan, C. Ferrell, W.L. Chandler Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma Thromb Res 120 2007 29 37
17. M.A. Borgman, P.C. Spinella, J.G. Perkins The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital J Trauma 63 2007 805 813
18. E.A. Gonzalez, F.A. Moore, J.B. Holcomb Fresh frozen plasma should be given earlier to patients requiring massive transfusion J Trauma 62 2007 112 119
19. J.B. Holcomb, C.E. Wade, J.E. Michalek Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients Ann Surg 248 2008 447 458
20. K. Brohi, M.J. Cohen, M.T. Ganter Acute coagulopathy of trauma: Hypoperfusion induces systemic anticoagulation and hyperfibrinolysis J Trauma 64 2008 1211 1217
21. G.J. Despotis, V. Levine, R. Saleem Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: A randomised controlled trial Lancet 354 1999 106 110
22. G.A. Nuttall, W.C. Oliver, P.J. Santrach Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass Anesthesiology 94 2001 773 781
23. M.S. Avidan, E.L. Alcock, J. Da Fonseca Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery Br J Anaesth 92 2004 178 186
24. S. Ogawa, F. Szlam, E.P. Chen A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery Transfusion 52 2012 14 22
25. J.B. Holcomb Optimal use of blood products in severely injured trauma patients Hematology Am Soc Hematol Educ Program 1 2010 465 469
26. T. Hannon Trauma blood management: Avoiding the collateral damage of trauma resuscitation protocols Hematology Am Soc Hematol Educ Program 1 2010 463 464
27. A.M. Ho, A. Lee, E. Ling Agreements between the prothrombin times of blood treated in vitro with heparinase during cardiopulmonary bypass (CPB) and blood sampled after CPB and systemic protamine Anesth Analg 96 2003 15 20
28. N. Urwyler, L.P. Staub, D. Beran Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test? Thromb Haemost 102 2009 779 786
29. K.A. Tanaka, N.S. Key, J.H. Levy Blood coagulation: Hemostasis and thrombin regulation Anesth Analg 108 2009 1433 1446
30. N.J. Breet, J.W. van Werkum, H.J. Bouman Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
31. N.J. Breet, J.W. van Werkum, H.J. Bouman High on-aspirin platelet reactivity as measured with aggregation-based, cyclooxygenase-1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events J Thromb Haemost 8 2010 2140 2148
32. J.L. Ferreiro, D. Sibbing, D.J. Angiolillo Platelet function testing and risk of bleeding complications Thromb Haemost 103 2010 1128 1135
33. K.A. Tanaka, W. Dietrich Is it time to implement preoperative platelet function testing before invasive procedures? Br J Anaesth 107 2011 842 843
34. R.M. Craft, J.J. Chavez, S.J. Bresee A novel modification of the Thromboelastograph assay, isolating platelet function, correlates with optical platelet aggregation J Lab Clin Med 143 2004 301 309
35. A. Afshari, A. Wikkelso, J. Brok Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion Cochrane Database Syst Rev 3 2011 CD007871
36. A. Levrat, A. Gros, L. Rugeri Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients Br J Anaesth 100 2008 792 797
37. H. Schöchl, T. Frietsch, M. Pavelka Hyperfibrinolysis after major trauma: Differential diagnosis of lysis patterns and prognostic value of thrombelastometry J Trauma 67 2009 125 131
38. R.J. Luddington Thrombelastography/thromboelastometry Clin Lab Haematol 27 2005 81 90
39. L.F. Venema, W.J. Post, H.G. Hendriks An assessment of clinical interchangeability of TEG and RoTEM thromboelastographic variables in cardiac surgical patients Anesth Analg 111 2010 339 344
40. D. Bolliger, M.D. Seeberger, K.A. Tanaka Principles and practice of thromboelastography in clinical coagulation management and transfusion practice Transfus Med Rev 26 2012 1 13
41. T. Lang, A. Bauters, S.L. Braun Multi-centre investigation on reference ranges for ROTEM thromboelastometry Blood Coagul Fibrinolysis 16 2005 301 310
42. T. Lang, W. Toller, M. Gütl Different effects of abciximab and cytochalasin D on clot strength in thrombelastography J Thromb Haemost 2 2004 147 153
43. M. Mittermayr, C. Velik-Salchner, B. Stalzer Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): Results of a pilot study Anesth Analg 108 2009 743 750
44. Z.M. Ruggeri Von Willebrand factor J Clin Invest 100 1997 S41 S46
45. E.I. Peerschke, M.B. Zucker, R.A. Grant Correlation between fibrinogen binding to human platelets and platelet aggregability Blood 55 1980 841 847
46. T.J. Hornyak, J.A. Shafer Interactions of factor XIII with fibrin as substrate and cofactor Biochemistry 31 1992 423 429
47. H. Ni, C.V. Denis, S. Subbarao Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen J Clin Invest 106 2000 385 392
48. E.P. Stover, L.C. Siegel, R. Parks Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: A 24-institution study Institutions of the Multicenter Study of Perioperative Ischemia Research Group Anesthesiology 88 1998 327 333
49. K. Karkouti, W.S. Beattie, D.N. Wijeysundera Recombinant factor VIIa for intractable blood loss after cardiac surgery: A propensity score-matched case-control analysis Transfusion 45 2005 26 34
50. G.J. Spalding, M. Hartrumpf, T. Sierig Cost reduction of perioperative coagulation management in cardiac surgery: Value of "bedside" thrombelastography (ROTEM) Eur J Cardiothorac Surg 31 2007 1052 1057
51. S.H. Lee, S.M. Lee, C.S. Kim Use of fibrin-based thromboelastometry for cryoprecipitate transfusion in cardiac surgery involving deep hypothermic circulatory arrest during cardiopulmonary bypass Blood Coagul Fibrinolysis 21 2010 687 691
52. O.H. Larsen, C. Fenger-Eriksen, K. Christiansen Diagnostic performance and therapeutic consequence of thromboelastometry activated by kaolin versus a panel of specific reagents Anesthesiology 115 2011 294 302
53. T. Lang, K. Johanning, H. Metzler The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia Anesth Analg 108 2009 751 758
54. P. Harrison, M.S. Robinson, I.J. Mackie Performance of the platelet function analyser PFA-100 in testing abnormalities of primary haemostasis Blood Coagul Fibrinolysis 10 1999 25 31
55. R. Paniccia, E. Antonucci, N. Maggini Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy Am J Clin Pathol 131 2009 834 842
56. U.S. Tantry, K.P. Bliden, P.A. Gurbel Overestimation of platelet aspirin resistance detection by thrombelastograph PlateletMapping and validation by conventional aggregometry using arachidonic acid stimulation J Am Coll Cardiol 46 2005 1705 1709
57. R.C. Carroll, R.M. Craft, R.J. Langdon Early evaluation of acute traumatic coagulopathy by thrombelastography Transl Res 154 2009 34 39
58. R.C. Carroll, R.E. Worthington, R.M. Craft Post interventional cardiology urinary thromboxane correlates with PlateletMapping detected aspirin resistance Thromb Res 125 2010 e118 e122
59. T.C. Collyer, D.J. Gray, R. Sandhu Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by thrombelastography PlateletMapping Br J Anaesth 102 2009 492 498
60. J.H. Levy, K.A. Tanaka, W. Dietrich Perioperative hemostatic management of patients treated with vitamin K antagonists Anesthesiology 109 2008 918 926
61. L. Rugeri, A. Levrat, J.S. David Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography J Thromb Haemost 5 2007 289 295
62. J.L. Kashuk, E.E. Moore, T. Le Noncitrated whole blood is optimal for evaluation of postinjury coagulopathy with point-of-care rapid thrombelastography J Surg Res 156 2009 133 138
63. D.C. Alexander, W.W. Butt, J.D. Best Correlation of thromboelastography with standard tests of anticoagulation in paediatric patients receiving extracorporeal life support Thromb Res 125 2010 387 392
64. C. Fenger-Eriksen, T.M. Jensen, B.S. Kristensen Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: A randomized, placebo-controlled clinical trial J Thromb Haemost 7 2009 795 802
65. D.F. O'Shaughnessy, C. Atterbury, P. Bolton Maggs Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant Br J Haematol 126 2004 11 28
66. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies Practice guidelines for perioperative blood transfusion and adjuvant therapies An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies Anesthesiology 105 2006 198 208
67. German Medical Association Cross-sectional guidelines for therapy with blood components and plasma derivatives 4th Revised edition Transfus Med Hemother 36 2009 419 436
68. D. Fries, P. Innerhofer, P. Perger Coagulation management in trauma-related massive bleeding - Recommendations of the Task Force for Coagulation (AGPG) of the Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine (OGARI) Anaesthesiol Intensivmed Notfallmed Schmerzther 45 2010 552 561
69. R. Rossaint, B. Bouillon, V. Cerny Management of bleeding following major trauma: An updated European guideline Crit Care 14 2010 R52
70. J.H. Levy, F. Szlam, K.A. Tanaka Fibrinogen and hemostasis: A primary hemostatic target for the management of acquired bleeding Anesth Analg 114 2012 261 274
71. B.E. Miller, T. Mochizuki, J.H. Levy Predicting and treating coagulopathies after cardiopulmonary bypass in children Anesth Analg 85 1997 1196 1202
72. N. Rahe-Meyer, M. Pichlmaier, A. Haverich Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: A pilot study Br J Anaesth 102 2009 785 792
73. T. Abshire, G. Kenet Recombinant factor VIIa: Review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors J Thromb Haemost 2 2004 899 909
74. M. Levi, J.H. Levy, H.F. Andersen Safety of recombinant activated factor VII in randomized clinical trials N Engl J Med 363 2010 1791 1800
75. S. Butenas, K.E. Brummel, R.F. Branda Mechanism of factor VIIa-dependent coagulation in hemophilia blood Blood 99 2002 923 930
76. M. Wasowicz, M. Meineri, S.M. McCluskey The utility of thromboelastography for guiding recombinant activated factor VII therapy for refractory hemorrhage after cardiac surgery J Cardiothorac Vasc Anesth 23 2009 828 834
77. M. Lak, B. Scharling, A. Blemings Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram Haemophilia 14 2008 103 110
78. B. Sorensen, P. Johansen, K. Christiansen Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation J Thromb Haemost 1 2003 551 558
79. G. Young, L.S. Ebbesen, D. Viuff Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: A multicentre trial Blood Coagul Fibrinolysis 19 2008 276 282
80. D. Viuff, S. Andersen, B.B. Sorensen Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven) therapy in haemophilia A patients Thromb Res 126 2010 144 149
81. J. Schneiderman, E. Rubin, D.J. Nugent Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: Update of our previous experience Haemophilia 13 2007 244 248
82. K.A. Tanaka, F. Szlam, C.P. Rusconi In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry Thromb Haemost 101 2009 827 833
83. R.M. Sniecinski, E.P. Chen, S.S. Makadia Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest J Cardiothorac Vasc Anesth 24 2010 959 963
84. N.R. Lewis, P. Brunker, S.J. Lemire Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage Transfusion 49 2009 689 695
85. D. Bolliger, F. Szlam, J.H. Levy Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: Implications for early haemostatic intervention in massive haemorrhage Br J Anaesth 104 2010 318 325
86. D. Bolliger, F. Szlam, R.J. Molinaro Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa Haemophilia 16 2010 510 517
87. J.J. Emeis Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products Ann N Y Acad Sci 667 1992 249 258
88. J.L. Kashuk, E.E. Moore, M. Sawyer Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma Ann Surg 252 2010 434 442
89. H. Shakur, I. Roberts, R. Bautista Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial Lancet 376 2010 23 32
90. J.D. Douketis, A.C. Spyropoulos, F.A. Spencer Perioperative management of antithrombotic therapy: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 141 2012 e326S e350S
91. R. Demeyere, S. Gillardin, J. Arnout Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: A randomized study Vox Sang 99 2010 251 260
92. M. Kikura, J.H. Levy, K.A. Tanaka A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery J Am Coll Surg 202 2006 216 222
93. D.A. Fergusson, P.C. Hébert, C.D. Mazer A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 2008 2319 2331
94. T.G. DeLoughery Logistics of massive transfusions Hematology Am Soc Hematol Educ Program 1 2010 470 473
95. P. Chowdary, P. Chowdhury, A.G. Saayman Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients Br J Haematol 125 2004 69 73
96. H.B. Riess, A. Meier-Hellmann, J. Motsch Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation Thromb Res 121 2007 9 16
97. I. Pabinger, B. Brenner, U. Kalina Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: A prospective multinational clinical trial J Thromb Haemost 6 2008 622 631
98. S. Ogawa, F. Szlam, T. Ohnishi A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions Thromb Haemost 106 2011 1215 1223
99. J.W. Johnson, V.H. Gracias, C.W. Schwab Evolution in damage control for exsanguinating penetrating abdominal injury J Trauma 51 2001 261 269
100. D. Bolliger, K. Görlinger, K.A. Tanaka Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution Anesthesiology 113 2010 1205 1219
101. C.R. Kaufmann, K.M. Dwyer, J.D. Crews Usefulness of thrombelastography in assessment of trauma patient coagulation J Trauma 42 1997 716 720
102. J.D. Roback, S. Caldwell, J. Carson Evidence-based practice guidelines for plasma transfusion Transfusion 50 2010 1227 1239
103. V.A. Ferraris, J.R. Brown, G.J. Despotis Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines Ann Thorac Surg 91 2011 944 982
104. S.J. Stanworth, S.J. Brunskill, C.J. Hyde Appraisal of the evidence for the clinical use of FFP and plasma fractions Best Pract Res Clin Haematol 19 2006 67 82
105. O.I. Abdel-Wahab, B. Healy, W.H. Dzik Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities Transfusion 46 2006 1279 1285